A plasma SNORD33 signature predicts platinum benefit in metastatic triple-negative breast cancer patients

• Biyun Wang,
• Yannan Zhao,
• Yi Li,
• Yingying Xu,
• Yun Chen,
• Qiuyu Jiang,
• Dingjin Yao,
• Li Zhang,
• Xichun Hu,
• Chaowei Fu,
• Si Zhang,
• She Chen

Affiliations

Biyun Wang

Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai Medical College, Fudan University

Yannan Zhao

Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai Medical College, Fudan University

Yi Li

Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai Medical College, Fudan University

Yingying Xu

NHC Key Laboratory of Glycoconjugate Research, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University

Yun Chen

School of Public Health, Key Laboratory of Public Health Safety, NHC Key Laboratory of Health Technology Assessment, Fudan University

Qiuyu Jiang

NHC Key Laboratory of Glycoconjugate Research, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University

Dingjin Yao

NHC Key Laboratory of Glycoconjugate Research, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University

Li Zhang

NHC Key Laboratory of Glycoconjugate Research, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University

Xichun Hu

Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai Medical College, Fudan University

Chaowei Fu

School of Public Health, Key Laboratory of Public Health Safety, NHC Key Laboratory of Health Technology Assessment, Fudan University

Si Zhang

NHC Key Laboratory of Glycoconjugate Research, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University

She Chen

NHC Key Laboratory of Glycoconjugate Research, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University